See What HealthDay Can Do For You
Contact Us

Clinical Trials Update Nov. 26, 2002

Multiple Sclerosis Insomnia Anxiety Disorders

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

A clinical research study to assess the safety and effectiveness of a study drug that may alleviate the symptoms of pathological laughing and/or crying (pseudobulbar affect) in individuals with multiple sclerosis (MS). Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

Insomnia

A phase II, double-blind, placebo-controlled, randomized, parallel-group study of the efficacy and safety of investigational tablets in the treatment of insomnia. Research site located in New York, New York.

More Information

Please see http://www.centerwatch.com/patient/studies/cat189.html.

-----

Anxiety Disorders

A research study on an investigational medication for the treatment of anxiety. Research site located in Woodstock, Vermont.

More Information

Please see http://www.centerwatch.com/patient/studies/cat14.html.

-----

Copyright 2002 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.